Age-Related Changes in the Clinical Picture of Long COVID
- PMID: 40888500
- DOI: 10.1111/jgs.70043
Age-Related Changes in the Clinical Picture of Long COVID
Abstract
Background: This study evaluated the impact of aging on the frequency and prevalent symptoms of Long COVID, also termed post-acute sequelae of SARS-CoV-2, using a previously developed Long COVID research index (LCRI) of 41 self-reported symptoms in which those with 12 or more points were classified as likely to have Long COVID.
Methods: We analyzed community-dwelling participants ≥ 60 years old (2662 with prior infection, 461 controls) compared to participants 18-59 years (7549 infected, 728 controls) in the Researching COVID to Enhance Recovery adult (RECOVER-Adult) cohort ≥ 135 days post-onset.
Results: Compared to the Age 18-39 group, the adjusted odds of LCRI ≥ 12 were higher for the Age 40-49 group (odds ratio [OR] = 1.40, 95% confidence intervals [CI] = 1.21-1.61, p < 0.001) and 50-59 group (OR = 1.31, CI = 1.14-1.51, p < 0.001), similar for the Age 60-69 group (OR = 1.09, CI = 0.93-1.27, p = 0.299), and lower for the ≥ 70 group (OR = 0.68, CI = 0.54-0.85, p < 0.001). Participants ≥ 70 years had smaller adjusted differences between infected and uninfected symptom prevalence rates than those aged 18-39 for the following symptoms: hearing loss, fatigue, pain (including joint, back, chest pain and headache), post-exertional malaise, sleep disturbance, hair loss, palpitations, and sexual desire/capacity, making these symptoms less discriminating for Long COVID in older adults than in younger. Symptom clustering, as described in Thaweethai et al. (JAMA 2023) also exhibited age-related shifts: clusters 1 (anosmia and ageusia) and 2 (gastrointestinal, chronic cough and palpitations, without anosmia, ageusia or brain fog) were more likely, and clusters 3 (brain fog, but no loss of smell or taste) and 4 (a mix of symptoms) less likely to be found in older adults (relative risk ratios for clusters 3-4 ranging from 0.10-0.34, p < 0.001 vs. 18-39 year-olds).
Conclusions: Within the limits of this observational study, we conclude that in community-dwelling older adults, aging alters the prevalence and pattern of reported Long COVID.
Keywords: Long COVID; age prevalence; epidemiology; older adults; patient‐reported outcomes.
© 2025 The American Geriatrics Society.
References
-
- W. Shang, Y. Wang, J. Yuan, et al., “Global Excess Mortality During COVID‐19 Pandemic: A Systematic Review and Meta‐Analysis,” Vaccines (Basel) 10 (2022): 1702, https://doi.org/10.3390/vaccines10101702.
-
- A. Sotoodeh Jahromi, M. Jokar, N. Sharifi, et al., “Systematic Review and Meta‐Analysis of Knowledge, Attitudes, and Practices Regarding COVID‐19 Among Chronic Disease Patients: A Global Perspective,” Health Sci Rep 7 (2024): e1793, https://doi.org/10.1002/hsr2.1793.
-
- D. M. Cutler, “The Costs of Long COVID,” JAMA Health Forum 3 (2022): e221809, https://doi.org/10.1001/jamahealthforum.2022.1809.
-
- K. Krstic, R. Westerman, V. K. Chattu, V. E. N, and M. Jakovljevic, “corona‐Triggered Global Macroeconomic Crisis of the Early 2020s,” International Journal of Environmental Research and Public Health 17 (2020): 9404, https://doi.org/10.3390/ijerph17249404.
-
- J. Nikolich‐Zugich, K. S. Knox, C. T. Rios, et al., “SARS‐CoV‐2 and COVID‐19 in Older Adults: What We May Expect Regarding Pathogenesis, Immune Responses, and Outcomes,” Geroscience 42 (2020): 505–514, https://doi.org/10.1007/s11357‐020‐00186‐0.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous